Welcure Drugs - WELCURE, 524661 corporate action history

Ex-Date	Bonus Ratio	Record Date
16 Oct 2025	1:10	16 Oct 2025

Ex-Date	Old FV	New FV	Record Date
16 Oct 2025	10	1	16 Oct 2025

Ex-Date	Purpose	Notes
29 May 2026	Audited Results	-
12 Feb 2026	Quarterly Results	-
05 Dec 2025	Right Issue of Equity Shares	-
27 Nov 2025	To consider raisinf of funds	Inter-alia, 1. To augment the financial resources of the Company via funds raising by way of issue of equity shares/convertible instruments/other securities through permissable modes.
13 Nov 2025	Quarterly Results	-
27 Sep 2025	Others	Inter-alia, 1. To take on record and deliberate upon the Letter of Intent (LOI) received from Telexcell Trade PTE LTD, Singapore, for a proposed acquisition of up to 25% equity stake (Revised)
02 Sep 2025	A.G.M.	-
28 Aug 2025	Others	Inter-alia, to consider 1. Proposed Agro-Pharma Research Laboratory. 2. Fund-raising by QIP.
22 Aug 2025	Bonus issue & Stock Split	-
05 Aug 2025	Quarterly Results & Others	Inter-alia, to consider 1. To change the Corporate Office of the Company. 2. Appoint an Additional Non- Executive Non- Independent & Independent Director's of the Company. 3. Other business matters.

Ex-Date	Ratio	Face Value	Premium	Record Date
01 Jan 1996	1.0:1.0	0.0	0.0	25 Jan 1996